Clinical Trials – HIV/Aids – Upcoming studies

Upcoming HIV/Aids studies

CHRU will be participating in the following clinical trials:

A5371

NCT To be confirmed

Protocol number/ title: A randomized, open-label pilot study of potential treatment strategies for non-alcoholic natty liver disease (NAFLD), a metabolic syndrome with insulin resistance, increased hepatic lipids, and increased cardiovascular disease risk.

Principal Investigator (PI) Interventional / Observational Closed/ Ongoing Start/
end date
Network Funders/ sponsors
To be confirmed

A5376

NCT To be confirmed

Protocol number/ title: The study looks at pharmacokinetic interactions of Etonogestrel Subdermal Implants (ENG) with Rilpivirine (RPV) Combined with Tenofovir Alafenamide (TAF) and Emtricitabine (FTC).

Principal Investigator (PI) Interventional / Observational Closed/ Ongoing Start/
end date
Network Funders/ sponsors
To be confirmed

A5381

NCT04050449

Protocol number/ title: Observational Cohort to Assess Therapeutic Efficacy and Emergence of HIV Drug Resistance Following Initiation of Tenofovir-Lamivudine-Dolutegravir (TLD) for First- or Second-Line ART or with Rifampin-Containing TB Treatment

PI Interventional / Observational Closed/ Ongoing Start/
end date
Network Funders/ sponsors
To be confirmed. To be confirmed. To be confirmed. To be confirmed. AIDS Clinical Trials Group (ACTG). To be confirmed.